Isoray to Present at the H.C. Wainwright BioConnect 2021 Conference
January 07 2021 - 8:13AM
Isoray, Inc. (NYSE American: ISR), a medical technology
company and seed brachytherapy innovator powering expanding
treatment options throughout the body, today announced that Chief
Executive Officer Lori Woods will present at the H.C. Wainwright
BioConnect 2021 Conference. The virtual conference will be held
January 11-14, 2021.
The on-demand presentation will be available on Isoray’s
Investor Relations section of the Company’s website at
https://isoray.com/investors/presentations/ at 6:00 a.m. EDT on
Monday, January 11, 2021. It will remain available on the website
for 90 days.
About IsorayIsoray, Inc., through its
subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131
brachytherapy seeds, which are expanding brachytherapy options
throughout the body. Learn more about this innovative Richland,
Washington company and explore the many benefits and uses of
Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn
and Twitter. Join us on Facebook.
Contact:
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
IsoRay (AMEX:ISR)
Historical Stock Chart
From Mar 2024 to Apr 2024
IsoRay (AMEX:ISR)
Historical Stock Chart
From Apr 2023 to Apr 2024
